NL-OMON53879尚未招募不适用
Can we use a simple blood test to reduce patients who will receive neoadjuvant chemoradiation by timely identification of radiotherapy-resistant rectal cancers? - MeD-Seq Rectal
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Age >18 - Histologically confirmed rectal adenocarcinoma - Scheduled for
- •neoadjuvant chemoradiation
排除标准
- •- Scheduled to another neoadjuvant schedule that comprises systemic
- •chemotherapy or short-course radiation
- •- Not able to read or understand Dutch language or mentally incompetent.
研究者
相似试验
尚未招募
不适用
Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal StudyPathological Response Rate, Circulating Tumour DNANCT06035471Erasmus Medical Center75
已完成
不适用
Bowel Cancer Screening with a Blood Test.ACTRN12615000299505Erin Symonds240
已完成
不适用
blood test to detect the presence or absence of cancerCTRI/2019/01/017166Epigeneres Biotech Pvt Ltd1,000
Unknown
不适用
A blood test to detect the presence or absence of cancerCTRI/2018/07/015116Epigeneres Biotech Pvt Ltd24
已完成
不适用
Test of re-verification of blood AGEs lowering effect (CML, 3-DG) and evaluation of effectiveness to the skins by intake of test food for 12 weeksHealthy adultJPRN-UMIN000042184EZAKI GLICO Co., Ltd.44